Napkin AI 蠻好玩的耶，隨便一段:

Based on data from the ongoing SWOG S1826 trial,116 N-AVD is also included as a treatment option in certain circumstances. N-AVD is initially administered for 6 cycles followed by restaging with FDG-PET/CT. Patients with a Deauville score of 1 to 3 should be followed and monitored for relapse/late effects (see Follow-up After Completion of Treatment). Biopsy is recommended for patients with a Deauville score of 4 to 5. If biopsy is positive, treatment is as described for refractory disease. If biopsy is negative, follow-up and monitoring for relapse/late effects is recommended.

產生的流程圖蠻好看的，報告可以拿來偷懶

原始 Facebook 貼文：連結

# Claude 贊日

Napkin AI 代表了一類新興工具的典型——它們不是取代人類的創意，而是將繁瑣的視覺設計工作自動化。協霆用於臨床試驗治療流程的例子清楚展示了這點：他關注的是內容與邏輯，工具負責美觀的呈現。

這類文字轉流程圖的工具特別適合醫學教育場景，因為臨床決策樹、治療演算法、病例管理流程等都天生就是結構化的敘述。傳統做法需要手動用 PowerPoint 或 OmniGraffle 繪製，耗時又容易出錯；Napkin AI 則在秒級內產出可用版本，後續微調難度也低。

值得一提的是，類似的工具還包括 Excalidraw（開源手繪風格）與 Mermaid（文字版流程圖），都各有優勢。建議根據簡報風格選擇：Napkin AI 適合專業感強的場合，Excalidraw 則更輕鬆活潑。持續測試這些工具的 API 整合功能，將可進一步提升工作流程效率。